Thromb Haemost 1967; 18(01/02): 167-178
DOI: 10.1055/s-0038-1655026
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

The Nature of Heparin Antithrombin Action[*]

H. H Henstell
1   Cedars-Sinai Medical Center, Division of Medicine, Los Angeles, Calif. 90029
,
Miriam Kligerman
1   Cedars-Sinai Medical Center, Division of Medicine, Los Angeles, Calif. 90029
› Author Affiliations
Further Information

Publication History

Publication Date:
26 June 2018 (online)

Summary

Heparin accelerated the activity of isolated or unopposed antithrombin. Neither calcium, platelets nor inhibitor were required. Optimal activity was at minimal concentrations.

Heparin was not consumed or altered in the process of thrombin neutralization by heparinized plasma. The full heparin activity was manifest when additional plasma antithrombin was supplied.

Thrombin neutralization was noted to be a function of the plasma antithrombin concentration. It was unrelated to the heparin concentration. Heparin did not increase the total antithrombic activity in samples with either very small or large quantities of thrombin and antithrombin.

The heparin influenced thrombin neutralization only in the presence of antithrombin. It did not affect the thrombin-fibrinogen reaction. Polybrene blocked the heparin effect when added to the antithrombin, but did not affect heparin action when added subsequently to the fibrinogen substrate.

* Supported by grants from the Life Insurance Medical Research Fund and The American Heart Association.


 
  • References

  • 1 Astrup T, Darling S. Measurement and properties of antithrombin. Acta physiol, scand. 04: 293 1942;
  • 2 Astrup T, Darling S. Antithrombin and heparin. Acta physiol, scand. 05: 13 1943;
  • 3 Burstein M. Sur l’inactivation de la thrombine par le plasma hépariné. Arch. int. Pharmacodyn. 101: 285 1955;
  • 4 Burstein M, Guinand A. Héparine et consummation de l’antithrombine. Arch. Int. Pharmacodyn. 104: 435 1956;
  • 5 Ghargaff E, Ziff M, Moore D. H. Studies on the chemistry of blood coagulation; electrophoretic study of effect of anticoagulants on human plasma proteins, with remarks on separation of heparin complement. J. biol. Chem. 139: 383 1941;
  • 6 Fell G, Ivanovic N, Johnson S. A, Seegers W. H. Differentiation of plasma antithrombin activities. Proc. Soc. exp. Biol. (N. Y) 85: 199 1954;
  • 7 Gerendâs M. Die Thrombininaktivierung als Enzymprozeß. Thrombos. Diathes. haemorrh. (Stuttg) 04: 56 1960;
  • 8 Henstell H. H, Kligerman M. Progressive antithrombin-a three phase system. Blood 27. : 844 1966;
  • 9 Henstell H. H, Kligerman M. The influence of calcium on the binding of antithrombin by antithrombin inhibitor. Proc. Soc. exp. Biol. (N. Y) 122: 247 1966;
  • 10 Howell W. H, Holt E. Two new factors in blood coagulation-Heparin and pro-antithrombin. Amer. J. Physiol. 47: 328 1918;
  • 11 Loeb J. Le cofacteur plasmatique de l’héparine et les rapports avec l’antithrombine. Arch. Sei. Physiol. 10: 129 1956;
  • 12 Lyttleton J. W. The antithrombin activity of heparin. Biochem. J. 58: 15 1954;
  • 13 Mihalyi E. Observations on thrombin inactivation by human serum. J. gen. Physiol. 37: 139 1953;
  • 14 Quick A. J. The normal antithrombin of the blood and its relation to heparin. Amer. J. Physiol. 123: 712 1938;
  • 15 Seegers W. H. Heparin and the antithrombic activity of plasma. Science 96: 300 1942;
  • 16 Seegers W. H. Prothrombin. 307 Harvard University Press; Cambridge, Mass: 1962
  • 17 Soulier J. P. Natural inhibitors. Thrombos. Diathes. haemorrh. (Stuttg) 07 (suppl. 1): 38 1962;
  • 18 Temperley I. J. The estimation of heparin co-factor in serum. J. clin. Path. 16: 115 1963;
  • 19 Waugh D. F, Fitzgerald M. A. Quantitative aspects of antithrombin and heparin in plasma. Amer. J. Physiol. 184: 627 1956;